Corevitas
Clinical trials sponsored by Corevitas, explained in plain language.
-
Massive psoriasis registry tracks Real-World drug safety
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a large registry that will follow 10,000 adults with psoriasis to see how safe and effective current treatments are in everyday medical practice. Researchers will track side effects like infections, heart problems, and cancer, as well as how well the treatments cont…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 26, 2026 04:51 UTC
-
Massive MS registry launches to track treatment safety in real time
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a large registry that will follow 1,000 adults with multiple sclerosis (MS) across North America. Researchers will collect data on how well approved MS treatments work and what side effects they cause in everyday medical practice. The goal is to better understand th…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 26, 2026 04:51 UTC
-
10,000 eczema patients enrolled in massive real-world drug safety study
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 10,000 adults with atopic dermatitis (eczema) to see how well approved treatments work and how safe they are in everyday medical practice. Researchers will also track the disease's natural history, related health problems, and current treatment patterns. Partic…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 26, 2026 04:49 UTC
-
Massive Alzheimer's registry launches to monitor drug safety in 2,000 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that collects information from about 2,000 people with mild cognitive impairment or Alzheimer's disease. Researchers will observe how the disease progresses and how treatments are used in everyday medical care. No new drugs or procedures are given; the go…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 26, 2026 04:38 UTC
-
2000 RA patients monitored for Real-World drug safety
Knowledge-focused OngoingThis study follows 2000 adults with rheumatoid arthritis in Japan to see how well different medications work and what side effects occur in everyday medical practice. Participants continue their normal prescribed treatments while researchers track joint pain, swelling, and seriou…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 26, 2026 04:33 UTC
-
800 NMOSD patients join landmark registry to unlock disease secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that will follow about 800 adults with neuromyelitis optica spectrum disorder (NMOSD) across North America. Researchers will collect information on how the disease presents, progresses, and is managed over time. The goal is to better understand NMOSD and …
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
New registry to track myasthenia gravis drug safety in 1,500 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that will follow about 1,500 adults with myasthenia gravis, a chronic nerve-muscle disease, to see how well their treatments work and what side effects occur. Participants receive no experimental drugs; instead, researchers collect data during regular doc…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
3,000 RA patients to donate blood for future breakthroughs
Knowledge-focused ENROLLING_BY_INVITATIONThis study is creating a large collection of blood samples from 3,000 people with rheumatoid arthritis. Researchers will use these samples to look for biomarkers that could help predict disease activity or side effects. Participants must already be in a registry and starting a ne…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC
-
Massive arthritis registry aims to uncover best treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that will follow up to 5,000 people with psoriatic arthritis or spondyloarthritis to see how well approved treatments work in everyday life. Researchers will track safety, disease patterns, and current treatment practices. Participants are already being e…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC
-
Thousands with IBD enrolled in massive real-world treatment tracker
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a large registry that follows over 2,200 adults with inflammatory bowel disease (IBD) across North America. It does not test new treatments but instead observes how approved therapies work in everyday practice, including their effectiveness, safety, and how the dise…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC
-
Massive RA registry to track drug safety in over 90,000 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis research registry follows over 91,000 adults with rheumatoid arthritis to see how well approved treatments work and how safe they are. Participants are cared for by rheumatologists across North America. The study does not test new drugs but collects real-world data to improv…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
PPDTM CorEvitasTM obesity (OBR) drug effectiveness and safety registry
ENROLLING_BY_INVITATIONThe design is an open-ended prospective observational (non-interventional) registry for subjects living with excess weight or obesity under the care of a qualified provider with documented experience treating patients with obesity
Sponsor: CorEvitas
Last updated May 22, 2026 13:51 UTC